In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
MSK scientists Andrew Kung and Elli Papaemmanuil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
Samuel Danishefsky
Memorial Sloan Kettering Enters Agreement to Develop New Cancer Drug

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
An MSK scientist pipettes in the lab
MSK Research Highlights, May 18, 2023

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.
Scott Lowe
Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.
Pictured: Jedd Wolchok and James Allison
In the News
The New Yorker Features Immune Therapy Work of Memorial Sloan Kettering Researchers

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.
Jeffrey Drebin
The Crucial Need for Cancer Treatment and Screening During COVID-19

In a recent interview, MSK's Dr. Jeffrey Drebin addressed why it’s important for people to keep up with their routine screenings and not put off cancer treatment or surgery.
Albert Kuchler with MSK medical oncologist Bob Li.
Harnessing the Power of Data for Patient Care

Computational biology is helping to bring predictive power and precision to oncology.
NBC’s Today Show Spotlights MSK and Addresses Access to Care at Comprehensive Cancer Centers
NBC’s Today Show Spotlights MSK and Addresses Access to Care at Comprehensive Cancer Centers

On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “How to Navigate Nation’s Top Hospitals.”
photo of sample blood vials
Finding
Could a Blood Test Detect Early-Stage Cancers?

A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening.
Petri dish with green mold on it
Science Byte
Insight into How Lungs Repel Infection Could Guide Therapies for Transplant Patients

Learn how immune cells in the lungs trigger invasive fungal cells to self-destruct. The discovery could produce therapies to prevent infection in cancer patients.